🇺🇸 FDA
Patent

US 11261214

Bicyclic peptide ligand specific for CD137

granted A61KA61K38/00A61K47/64

Quick answer

US patent 11261214 (Bicyclic peptide ligand specific for CD137) held by BicycleTx Limited expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleTx Limited
Grant date
Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/00, A61K47/64